This announcement is a separate document:
北京植德律师事务所关于长春百克生物科技股份公司调整2022年限制性股票激励计划限制性股票授予价格的法律意见书
Legal Opinion of Beijing Zhide Law Firm on Changchun Baike Biotechnology Co., Ltd. adjusting the price granted for restricted shares under the 2022 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.